Centre Asset Management Has Trimmed Microsoft (MSFT) Position; Last Week Natus Medical (BABY) Coverage

Among 5 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Natus Medical has $55 highest and $39 lowest target. $48’s average target is 50.00% above currents $32 stock price. Natus Medical had 11 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by TH Capital with “Buy” on Tuesday, January 12. The firm has “Buy” rating by Roth Capital given on Friday, June 23. As per Thursday, February 2, the company rating was downgraded by Raymond James. The stock of Natus Medical Incorporated (NASDAQ:BABY) earned “Buy” rating by Roth Capital on Tuesday, April 5. The company was maintained on Tuesday, February 27 by Roth Capital. The stock has “Hold” rating by William Blair on Monday, January 8. The firm has “Outperform” rating given on Tuesday, September 13 by Raymond James. On Tuesday, October 4 the stock rating was initiated by Benchmark with “Buy”. The stock has “Buy” rating by TH Capital on Thursday, July 23. The firm earned “Buy” rating on Thursday, October 22 by TH Capital. See Natus Medical Incorporated (NASDAQ:BABY) latest ratings:

27/02/2018 Broker: Roth Capital Old Rating: Buy New Rating: Buy New Target: $39 Maintain
08/01/2018 Broker: William Blair Rating: Hold Downgrade
11/09/2017 Broker: Roth Capital Rating: Buy New Target: $44.0 Maintain

Centre Asset Management Llc decreased Microsoft Corp (MSFT) stake by 1.61% reported in 2017Q3 SEC filing. Centre Asset Management Llc sold 4,380 shares as Microsoft Corp (MSFT)’s stock rose 4.75%. The Centre Asset Management Llc holds 268,177 shares with $19.98M value, down from 272,557 last quarter. Microsoft Corp now has $727.09B valuation. The stock increased 0.61% or $0.57 during the last trading session, reaching $94.43. About 25.89M shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 34.52% since March 9, 2017 and is uptrending. It has outperformed by 17.82% the S&P500.

Since September 14, 2017, it had 0 buys, and 2 insider sales for $281,448 activity. $154,748 worth of Natus Medical Incorporated (NASDAQ:BABY) was sold by GUNST ROBERT A on Thursday, September 14. Another trade for 4,000 shares valued at $126,700 was sold by LUDLUM KEN.

The stock decreased 0.78% or $0.25 during the last trading session, reaching $32. About 205,201 shares traded. Natus Medical Incorporated (NASDAQ:BABY) has risen 4.38% since March 9, 2017 and is uptrending. It has underperformed by 12.32% the S&P500.

Investors sentiment decreased to 0.71 in 2017 Q3. Its down 0.05, from 0.76 in 2017Q2. It is negative, as 32 investors sold Natus Medical Incorporated shares while 70 reduced holdings. 20 funds opened positions while 58 raised stakes. 30.60 million shares or 0.12% more from 30.57 million shares in 2017Q2 were reported. Deutsche Bancorporation Ag accumulated 30,271 shares. Thrivent For Lutherans has 20,320 shares for 0% of their portfolio. Kennedy Mgmt stated it has 0.06% in Natus Medical Incorporated (NASDAQ:BABY). Swiss Commercial Bank accumulated 54,100 shares. Hillcrest Asset Mngmt Lc, a Texas-based fund reported 239,089 shares. Ashford Capital Mgmt Incorporated has 12,592 shares for 0.08% of their portfolio. State Of Alaska Department Of Revenue holds 6,557 shares. State Street Corporation holds 0% or 867,337 shares in its portfolio. Manufacturers Life Insur The has 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 24,660 shares. Virginia Retirement System Et Al accumulated 36,200 shares or 0.02% of the stock. Louisiana State Employees Retirement System stated it has 0.02% in Natus Medical Incorporated (NASDAQ:BABY). State Of Tennessee Treasury Department accumulated 0.01% or 29,269 shares. Olstein Capital Lp stated it has 86,200 shares. Sentinel Asset Mgmt reported 0.25% in Natus Medical Incorporated (NASDAQ:BABY). Pub Employees Retirement Association Of Colorado has 8,057 shares for 0% of their portfolio.

Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of $980.60 million. It offers services and products used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. It currently has negative earnings. The companyÂ’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 29 have Buy rating, 2 Sell and 6 Hold. Therefore 78% are positive. Microsoft Corporation has $118.0 highest and $20 lowest target. $88.96’s average target is -5.79% below currents $94.43 stock price. Microsoft Corporation had 167 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Friday, October 23 by Stifel Nicolaus. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Buy” rating given on Monday, July 17 by Bank of America. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Strong-Buy” rating given on Thursday, August 27 by Vetr. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Buy” rating by RBC Capital Markets on Sunday, October 8. Jefferies maintained it with “Sell” rating and $49.0 target in Tuesday, August 22 report. UBS maintained Microsoft Corporation (NASDAQ:MSFT) rating on Friday, October 21. UBS has “Buy” rating and $66 target. The company was maintained on Wednesday, October 11 by Credit Suisse. The rating was maintained by Jefferies with “Sell” on Thursday, February 1. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Outperform” rating by FBN Securities on Wednesday, July 20. The company was upgraded on Monday, November 30 by Raymond James.

Investors sentiment decreased to 0.77 in Q3 2017. Its down 0.06, from 0.83 in 2017Q2. It worsened, as 40 investors sold MSFT shares while 952 reduced holdings. 114 funds opened positions while 708 raised stakes. 5.51 billion shares or 0.32% less from 5.53 billion shares in 2017Q2 were reported. Dorsey And Whitney Company Ltd Limited Liability Company reported 131,285 shares. Boston Family Office Lc has 0.94% invested in Microsoft Corporation (NASDAQ:MSFT) for 111,349 shares. New England And Mgmt holds 18,465 shares or 1.01% of its portfolio. Bellecapital Intll Limited holds 0.56% or 6,325 shares in its portfolio. Leisure Cap Management invested in 2.3% or 35,162 shares. Omega Advsr stated it has 1.16 million shares or 3.36% of all its holdings. American & Mngmt, Massachusetts-based fund reported 26,712 shares. Town Country Savings Bank Tru Dba First Bankers Tru has invested 2.61% in Microsoft Corporation (NASDAQ:MSFT). West Family Investments has 42,400 shares. Systematic Mngmt LP reported 70,233 shares. Staley Capital Advisers invested in 4.53% or 745,008 shares. Rosenbaum Jay D invested in 4.17% or 29,225 shares. Moreover, Morgan Stanley has 1.39% invested in Microsoft Corporation (NASDAQ:MSFT) for 62.21M shares. Boston Common Asset Ltd has 235,574 shares for 2.19% of their portfolio. Spc stated it has 58,401 shares.

Since February 16, 2018, it had 0 buys, and 3 selling transactions for $930,912 activity. 3,500 Microsoft Corporation (NASDAQ:MSFT) shares with value of $325,500 were sold by Capossela Christopher C.

Analysts await Microsoft Corporation (NASDAQ:MSFT) to report earnings on April, 26. They expect $0.85 earnings per share, up 16.44% or $0.12 from last year’s $0.73 per share. MSFT’s profit will be $6.54B for 27.77 P/E if the $0.85 EPS becomes a reality. After $0.96 actual earnings per share reported by Microsoft Corporation for the previous quarter, Wall Street now forecasts -11.46% negative EPS growth.